Hubei Xingfa Chemicals Group Co., Ltd. (SHA:600141)
China flag China · Delayed Price · Currency is CNY
32.01
-0.86 (-2.62%)
May 25, 2026, 3:00 PM CST

SHA:600141 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
29,10728,88327,95327,74129,59323,332
Other Revenue
416.24416.24443.9540.3717.79570.02
29,52329,30028,39628,28130,31123,902
Revenue Growth (YoY)
2.73%3.18%0.41%-6.69%26.81%30.49%
Cost of Revenue
24,31524,17623,07223,90219,68515,919
Gross Profit
5,2085,1245,3254,38010,6267,983
Selling, General & Admin
997.68934.251,008832.85823.21641.17
Research & Development
1,3231,3141,1831,1171,232862.18
Other Operating Expenses
424.44456.21481.5322.47256.33205.07
Operating Expenses
2,7562,7182,6862,2692,3141,699
Operating Income
2,4522,4062,6392,1108,3126,284
Interest Expense
-451.85-448.15-418.2-371.4-364.36-520.05
Interest & Investment Income
152.15169.29144.11161.66316.46310.69
Currency Exchange Gain (Loss)
14.8114.8168.0836.1380.44-6.14
Other Non Operating Income (Expenses)
27.2850.79-48.91-80.87-125.52-119.83
EBT Excluding Unusual Items
2,1942,1932,3841,8568,2195,948
Impairment of Goodwill
-47.94-47.94-233.89-120.3-24.59-2.52
Gain (Loss) on Sale of Investments
-23.141.59-22.658.73-100.880.41
Gain (Loss) on Sale of Assets
-87.81-89.97-63.04-91.03-297.25-466.05
Asset Writedown
-1.49-1.96-0.45-27.23-22.88-127.43
Other Unusual Items
110.14110.1419.54119.2897.6270.71
Pretax Income
2,1442,1652,0831,7457,8715,423
Income Tax Expense
530.69552.46464.7336.671,074689.58
Earnings From Continuing Operations
1,6131,6121,6191,4096,7964,734
Minority Interest in Earnings
-175.37-120.22-17.39-7.96-944.61-452.12
Net Income
1,4381,4921,6011,4015,8524,282
Net Income to Common
1,4381,4921,6011,4015,8524,282
Net Income Growth
-6.03%-6.83%14.33%-76.06%36.67%589.24%
Shares Outstanding (Basic)
1,1201,1051,1041,1211,1021,104
Shares Outstanding (Diluted)
1,1431,1391,1441,1971,1231,112
Shares Change (YoY)
0.06%-0.43%-4.45%6.59%0.99%7.41%
EPS (Basic)
1.281.351.451.255.313.88
EPS (Diluted)
1.261.311.401.175.213.85
EPS Growth
-6.08%-6.43%19.66%-77.54%35.33%541.67%
Free Cash Flow
-1,609-633.8485.24-1,0964,5203,827
Free Cash Flow Per Share
-1.41-0.560.07-0.924.023.44
Dividend Per Share
0.5000.5001.0000.6001.0000.500
Dividend Growth
-50.00%-50.00%66.67%-40.00%100.00%100.00%
Gross Margin
17.64%17.49%18.75%15.49%35.06%33.40%
Operating Margin
8.30%8.21%9.29%7.46%27.42%26.29%
Profit Margin
4.87%5.09%5.64%4.95%19.31%17.91%
Free Cash Flow Margin
-5.45%-2.16%0.30%-3.88%14.91%16.01%
EBITDA
5,3465,1804,9324,1459,9747,547
EBITDA Margin
18.11%17.68%17.37%14.66%32.91%31.57%
D&A For EBITDA
2,8942,7742,2942,0341,6621,263
EBIT
2,4522,4062,6392,1108,3126,284
EBIT Margin
8.30%8.21%9.29%7.46%27.42%26.29%
Effective Tax Rate
24.75%25.52%22.30%19.29%13.65%12.72%
Revenue as Reported
29,52329,30028,39628,28130,31123,902
Source: S&P Global Market Intelligence. Standard template. Financial Sources.